A bond is a debt security that can be traded freely on the open market and represents part of a loan. Bonds are an ideal diversification tool for investors. There are a number of reasons why investing ...

Cloudberry Clean Energy ASA ("Cloudberry" or the "Company) has entered into an agreement with a European infrastructure investor ("the Investor") to establish one of the largest small-scale hydro ...

Soiltech ASA (OSE: STECH) Sandnes, Norway, 09 July 2025 Soiltech is pleased to announce the successful refinancing of its existing credit facilities totalling NOK 234 million. The company has entered ...

Press ReleaseVELIZY-VILLACOUBLAY, France — July 7, 2025 Half-year statement of the Liquidity contract entered into with Oddo BHF SCA Das ...

is owned by HC (60%) and HSC (40%). The condition for completion of the Offer relating to "Minimum Acceptance" as set out in section 1.3 of the Offer Document has, as previously announced, already ...

In June 2025, Höegh Autoliners (the Company, ticker code “HAUTO”) transported 1.3 million cbm of cargo on prorated basis. Transported c ...

(July 9, 2025 - Oslo, Norway) Nel ASA (Nel, OSE:NEL) will publish its second quarter 2025 report on 16 July 2025 at 07:00 CET, and host a pr ...

9 July 2025: Borregaard ASA ("Borregaard", OSE ticker: BRG) Presentation of Q2 2025 results Borregaard will report second quarter 2025 resul ...

Home Equities - Stocks - Shares Company Press Releases Ensurge Micropower ASA - Business Update and Contemplated Fully Underwritten Private Placement ...

Miami, FL, July 09, 2025 Atlantic Sapphire ASA (along with its subsidiaries the "Company") has harvested a total volume of approximately 1,167t HOG in the three months ending June 30, 2025 (Q1 2025: ...

Fornebu, Norway – 8 July 2025 – Telenor announces the acquisition of GlobalConnect’s consumer business in Norway in a transaction valued at NOK 6.0 billion. The deal marks a significant strategic step ...

Oslo, Norway, July 9, 2025 – Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced that a ...